Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR‐520a‐3p/LIMK1 axis
Abstract Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer‐related deaths globally. Herein, we explored the underlying mechanism by which Propofol inhibited the development of HCC. Methods 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay was car...
Main Authors: | Dongmei Wang, Na Xing, Tao Yang, Junqi Liu, Huaping Zhao, Juan He, Yanqiu Ai, Jianjun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3313 |
Similar Items
-
Structural Aspects of LIMK Regulation and Pharmacology
by: Deep Chatterjee, et al.
Published: (2022-01-01) -
LncRNA SNHG16 drives proliferation, migration, and invasion of hemangioma endothelial cell through modulation of miR‐520d‐3p/STAT3 axis
by: Wenke Zhao, et al.
Published: (2018-07-01) -
Dorsal visual stream and LIMK1: hemideletion, haplotype, and enduring effects in children with Williams syndrome
by: J. Shane Kippenhan, et al.
Published: (2023-08-01) -
LIMK1/2 inhibitor LIMKi 3 suppresses porcine oocyte maturation
by: Ru-Xia Jia, et al.
Published: (2016-10-01) -
Identification of LIMK1 as a biomarker in clear cell renal cell carcinoma: from data mining to validation
by: Yifei Li, et al.
Published: (2025-03-01)